NEUPHORIA THERAPEUTICS INC (NEUP) Stock Balance Sheet
NASDAQ:NEUP • US64136E1029
Current stock price
4.57 USD
-0.04 (-0.87%)
At close:
4.57 USD
0 (0%)
After Hours:
| MRQ (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 18.25M | 23.16M | |||
| Cash Equivalents | 22.17M | 14.21M | 12.61M | 12.10M | N/A | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 1.11M | 12.00K | 127.00K | 426.00K | 4.68M | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 106.60K | 818.00K | 459.00K | 797.00K | 1.01M | |||
| Total Current Assets | 23.39M | 15.04M | 13.19M | 13.33M | 28.85M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 105.00K | 219.00K | 333.00K | 465.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 82.00K | |||
| Goodwill | 8.74M | 8.64M | 8.69M | 8.69M | 8.88M | |||
| Intangibles | 4.47M | 4.80M | 5.47M | 6.13M | 6.79M | |||
| Other Non-Current Assets | N/A | 0.00 | 79.00K | 79.00K | N/A | |||
| Total Non-Current Assets | 13.21M | 13.55M | 14.46M | 15.24M | 16.22M | |||
| TOTAL ASSETS | 36.60M | 28.59M | 27.65M | 28.56M | 45.07M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 33.50K | 33.00K | 33.00K | 33.00K | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 171.80K | 110.00K | |||
| Accrued Expenses | 1.93M | 3.00M | 1.53M | 1.23M | 1.06M | |||
| Accounts Payable | 520.70K | 1.15M | 2.24M | 1.44M | 1.07M | |||
| Other Current Liabilities | 99.90K | 36.00K | 18.00K | 39.00K | 282.00K | |||
| Total Current Liabilities | 2.59M | 4.22M | 3.83M | 2.74M | 1.47M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 368.00K | |||
| Deferred Taxes/Income | 425.50K | 495.00K | 964.00K | 1.10M | 1.24M | |||
| Other Non-Current Liabilities | 3.89M | 4.87M | 5.37M | 2.71M | 1.87M | |||
| Total Non-Current Liabilities | 4.31M | 5.37M | 6.33M | 3.81M | 3.48M | |||
| TOTAL LIABILITIES | 6.90M | 9.59M | 10.16M | 6.55M | 4.95M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -186.39M | -178.35M | -177.98M | -162.49M | -115.22M | |||
| Additional Paid In Capital | 218.32M | 200.19M | 198.48M | 187.55M | N/A | |||
| Common Shares | 100.00 | 0.00 | 0.00 | 0.00 | 140.26M | |||
| Other Shareholders' Equity | -2.23M | -2.85M | -3.01M | -3.06M | 4.27M | |||
| Shares Outstanding | 5.38M | 1.98M | 198.70M | 122.39M | 112.77M | |||
| Tangible Book Value per Share | 3.07 | 2.81 | 0.02 | 0.06 | -1.12 | |||
| Total Shareholders' Equity | 29.70M | 19.00M | 17.49M | 22.01M | -110.96M | |||
| TOTAL LIABILITIES AND EQUITY | 36.60M | 28.59M | 27.65M | 28.56M | -106.01M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | -0.00 | |||
| Current Ratio | 9.04 | 3.56 | 3.45 | 4.87 | 19.67 | |||
| Return On Assets (ROA) | -15.48% | -1.29% | -56.03% | -74.86% | -35.01% | |||
| Return On Equity (ROE) | -19.07% | -1.95% | -88.58% | -97.14% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21